Chandra Bhagat

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE07QQ01016
  • NSEID:
  • BSEID: 542934
INR
35.00
0.00 (0.00%)
BSENSE

Dec 03

BSE+NSE Vol: 3000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003380,
    "name": "Chandra Bhagat",
    "stock_name": "Chandra Bhagat",
    "full_name": "Chandra Bhagat Pharma Ltd",
    "name_url": "stocks-analysis/chandra-bhagat",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "35.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "35.00",
    "mcapval": "29.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 542934,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE07QQ01016",
    "curr_date": "Dec 03",
    "curr_time": "",
    "bse_nse_vol": 3000,
    "exc_status": "Active",
    "traded_date": "Dec 03, 2025",
    "traded_date_str": "2025 12 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/chandra-bhagat-1003380-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Chandra Bhagat?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-chandra-bhagat-3699587",
        "imagepath": "",
        "date": "2025-11-13 23:42:53",
        "description": "Answer:\nThe historical performance of Chandra Bhagat shows significant fluctuations in key financial metrics over the years.\n\nBreakdown:\nChandra Bhagat's net sales peaked at 221.37 Cr in March 2024 but dropped to 86.72 Cr by March 2025. The total operating income followed a similar trend, decreasing from 221.37 Cr in March 2024 to 86.72 Cr in March 2025. The total expenditure also saw a decline, from 228.42 Cr in March 2024 to 88.18 Cr in March 2025. Operating profit (PBDIT) was negative in both March 2025 and March 2024, at -1.46 Cr and -7.05 Cr respectively, indicating a challenging operational environment. Profit before tax showed a slight decrease from 2.26 Cr in March 2024 to 1.17 Cr in March 2025, while profit after tax also fell from 1.53 Cr to 0.86 Cr in the same period. The company's total assets remained relatively stable, slightly decreasing from 101.78 Cr in March 2024 to 101.46 Cr in March 2025..."
      }
    ],
    "total": 8,
    "sid": "1003380",
    "stock_news_url": "https://www.marketsmojo.com/news/chandra-bhagat-pharma-1003380"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th November 2025 For Approval Of Un-Audited Result As On 30.09.2025",
      "datetime": "13-Nov-2025",
      "details": "Outcome of the Board Meeting held on 13th November 2025.",
      "source": "BSE"
    },
    {
      "caption": "Un-Audited Result For Half Year Ended September 30 2025.",
      "datetime": "13-Nov-2025",
      "details": "Outcome of the Board Meeting held on 13th November 2025 for approval of un-audited result as on 30th September 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for For Approval Of Un-Audited Result For The Half Year Ended 30Th September 2025",
      "datetime": "07-Nov-2025",
      "details": "Chandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve Un-audited result for half year ended 30th September 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th November 2025 For Approval Of Un-Audited Result As On 30.09.2025

13-Nov-2025 | Source : BSE

Outcome of the Board Meeting held on 13th November 2025.

Un-Audited Result For Half Year Ended September 30 2025.

13-Nov-2025 | Source : BSE

Outcome of the Board Meeting held on 13th November 2025 for approval of un-audited result as on 30th September 2025.

Board Meeting Intimation for For Approval Of Un-Audited Result For The Half Year Ended 30Th September 2025

07-Nov-2025 | Source : BSE

Chandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve Un-audited result for half year ended 30th September 2025.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available